Multiple emulsion technology provides a mechanism for the encapsulatio
n and in vivo delivery of drugs, proteins, and other materials which w
ould otherwise be degraded, cleared rapidly, or toxic to the host. The
se feasibility studies were performed to evaluate a prototype Hb multi
ple emulsion as a stable oxygen delivery system. A concentrated soluti
on of hemoglobin (Hb) was encapsulated in the form of a Hb-in-oil-in-w
ater (Hb/O/W) multiple emulsion. Studies using mineral oil demonstrate
d that Hb multiple emulsions have several important characteristics th
at are compatible with utility as a blood substitute, These include: s
atisfactory rheological properties and good hydrodynamic stability com
pared to whole blood, high encapsulation concentration of Hb and high
encapsulation efficiency with little met-hemoglobin generation, and sa
tisfactory oxygen affinity and cooperativity compared to whole blood.
Isovolemic exchange transfusions of Hb/O/W multiple emulsion can suppo
rt life in rats whose hematocrit has been reduced to levels (5% or low
er) that are incompatible with survival, and induces no acute toxicity
. These results are consistent with the utility of Hb/O/W as an oxygen
-carrying red blood cell substitute or organ perfusion media.